Thermo Fisher Scientific will build and operate a 44,000-square-foot, state-of-the-art cell therapy collaboration center on the UCSF Mission Bay campus. Expected to open in 2022, the facility will serve as a central location where customers and UCSF researchers will have access to Thermo Fisher Scientific’s broad portfolio of solutions and clinical and commercial cGMP cell therapy manufacturing services, along with associated technology development support to UCSF and other partners.
Learn how the new state-of-the-art cell therapy manufacturing and collaboration center on University of California, San Francisco Mission Bay campus will empower researchers to scale future clinical campaigns.
Connect to the integrated solutions that support your cell therapy development at every stage. Learn how we can help you translate your cell therapy from discovery to clinical research all the way through to cell therapy commercialization.
We offer high-quality products for every stage of development, regulatory documentation and support, and access to expert consultation—allowing for seamless transition from basic research to the clinic and commercialization.